• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Capital Health Launches COVID-19 Antibody Testing Initiative


News provided by

Capital Health

Apr 24, 2020, 20:40 ET

Share this article

Share this article


TRENTON, N.J., April 24, 2020 /PRNewswire/ -- Before the COVID-19 pandemic reached the United States, it was clear that health care workers on the front lines were at an extremely high risk for infection. As health care organizations in New Jersey and around the country confronted the crisis and began providing adequate personal protective equipment (PPE), education, and guidance to their teams, Capital Health worked to advance mitigation efforts further by developing a COVID-19 blood antibody screening program. The research began by assessing the presence of COVID-19 immunity in Capital Health's workforce.

Eugene McMahon, MD
Eugene McMahon, MD
Robert Remstein, DO
Robert Remstein, DO
Patrick De Deyne, MPT, MS, PhD
Patrick De Deyne, MPT, MS, PhD
Eugene McMahon, MD Robert Remstein, DO Patrick De Deyne, MPT, MS, PhD

A person infected with COVID- 19 produces specific IgG antibodies that can be detected in blood samples, whether they're exhibiting mild symptoms, a serious illness, or no symptoms at all. The presence of this specific antibody indicates that a person has produced an immune response to COVID-19.

"Testing for the presence of the IgG antibody among our employees was a natural starting point for this study. Like health care workers all over the world, they're looking this health crisis in the eye every day," said Dr. Eugene McMahon, chief medical officer at Capital Health. "As the medical community's understanding of COVID-19 evolves, we believe that our antibody testing research will assist health care providers and patients alike."

Led by Patrick De Deyne, PhD, director of Clinical Research at Capital Health, the IgG antibody research initiative began in mid-April with more than 1,200 employee volunteers contributing blood samples for the study. Capital Health then partnered with FlowMetric, Inc., a biotechnical laboratory located in Doylestown, Pennsylvania, to create a screening program that follows the industry's exacting protocols and high ethical standards. Through this collaboration, Capital Health demonstrates how regional medical centers have important roles in the development of new diagnostics and treatments in medicine. After making each volunteer aware of their immune status, the goal of this study is to inform the medical community about the existence of immunity to COVID-19 in health care settings and eventually the population at large.

"In order to continue to deliver the level of care that the people of central New Jersey and southeastern Pennsylvania expect, Capital Health needs to support its employees," said Dr. Robert Remstein, director of Accountable Care at Capital Health. "So far, the study has yielded significant information from employees at Capital Health, much of which can be applied to epidemiologic studies of the community and beyond."

Drs. McMahon, Remstein and De Deyne are available for interviews. For more information about the Capital Health IgG antibody research initiative, contact the Public Relations Department at 609-394-6091 or [email protected].

About Capital Health

Capital Health is the Central New Jersey/Lower Bucks County region's leader in providing progressive, quality patient care. Comprised of two hospitals (Capital Health Regional Medical Center in Trenton and Capital Health Medical Center – Hopewell), a Hamilton outpatient facility, and various primary and specialty care practices across the region, Capital Health is a dynamic health care resource accredited by DNV GL – Healthcare, and a four-time Magnet-designated health system for nursing excellence.

Bios:

Eugene J. McMahon, MD, MBA, FCAP

Senior Vice President & Chief Medical Officer

As chief medical officer (CMO), Dr. Eugene McMahon is responsible for ensuring the provision of high quality and efficient medical care at Capital Health. He serves as the primary liaison between hospital administration and medical staff. As a member of Capital Health's senior management team, he provides medical practice delivery development, implementation and evaluation in accordance with the goals of Capital Health's medical programs.

Dr. McMahon's expertise includes implementing successful clinical and physician practice models; recruiting strong physician and clinical team members; building alignment among medical staff members and other health care professionals behind shared goals; improving efficiency and quality; and managing resources in an effective manner to drive long-term growth for organizations.

Dr. McMahon is a board certified pathologist and began his practice in 1994 in Milwaukee. His experience includes serving as the leader of an 18-person Pathology and Laboratory Medicine practice and serving on five medical staffs in the Milwaukee area. Dr. McMahon is also a licensed physician in several states. Prior to becoming president & CEO at Saint Joseph Hospital (Chicago, IL), Dr. McMahon served in a series of progressive leadership positions, including chief medical officer and vice president of medical affairs at other health care institutions.

Dr. McMahon graduated cum laude from the College of the Holy Cross, Worcester, Massachusetts, with a bachelor's degree in economics and pre-medicine, before earning his MD from Georgetown University School of Medicine, Washington, D.C. Following an internal medicine internship at Columbia University, New York, he completed a residency in pathology and laboratory medicine at Georgetown University Medical Center. Dr. McMahon also holds an MBA from the Kellogg School of Management at Northwestern University, Evanston, Illinois.

Robert Remstein, DO, MBA

Vice President, Accountable Care

Designated Institutional Official for Graduate Medical Education

As the Vice President for Accountable Care, Dr. Remstein is responsible for Capital Health's moves toward becoming a leader in population health.  He works with other members of the hospital leadership team to develop the outpatient network, and programs that address clinical integration across the care continuum; helping Capital Health to remain competitive in the changing health care environment. 

As the Designated Institutional Official, Dr. Remstein oversees the education and training of all medical students and resident physicians at Capital Health.  He is guiding the growth of graduate medical education at Capital to become an academic medical center.

Prior to his current position, Dr. Remstein served as vice president of Medical Affairs at Capital Health. He has been a member of the Capital Health medical staff for more than 27 years serving in many voluntary leadership positions. Dr. Remstein is a founding member and current president of the Trenton Health Team, an organization supported by Capital Health to further the development of an urban accountable care organization. His background as a physician practicing in the community, coupled with his successful experience in working with his colleagues on the Capital Health medical staff on matters ranging from the clinical to administrative, uniquely qualifies him for this important position.

Dr. Remstein received his medical degree from New York College of Osteopathic Medicine and completed a residency in internal medicine at Albert Einstein Medical Center, PA. He previously served as Medical Director of Henry J. Austin Health Care Center in Trenton, and was a founding member of Mercer Internal Medicine Associates.  He is also a practicing internist and is the Medical Director of Capital Health Primary Care – Newtown, Pennsylvania.

Patrick G. De Deyne, MPT, MS, PhD

Director of Clinical Research at Capital Health

Patrick De Deyne, MPT, PhD is the Director of Clinical Research at Capital Health System, Inc. where he leads the research strategy, clinical research operations, and regulatory affairs. He manages a portfolio that encompasses physician-initiated research as well as sponsored trials from industry and the federal government.

Dr. De Deyne has a professional background in academic research and teaching as well as industry experience in the development of innovative therapies. Dr. De Deyne received graduate training in Physical Therapy, Biomechanics (MSc), Anatomy & Cell Biology (PhD), and Clinical Research Methods from several Universities in the USA and in EU. His doctoral training led him to the University of Maryland School of Medicine where he had faculty appointments in the Departments of Orthopedic Surgery and Physiology and subsequently his academic endeavors led him to research and development initiatives with progressive levels of responsibilities in Regenerative Medicine at Johnson & Johnson and then functioned as the Director of R&D at LifeCell (now Allergan). He returned to academics when he joined Temple University School of Medicine where he led Clinical Research Development for the Temple Clinical Research Institute. Dr. De Deyne has published more than 40 peer-reviewed manuscripts, holds several invention disclosures, and has been an invited speaker at multiple international conferences.

SOURCE Capital Health

Related Links

http://capitalhealth.org

Modal title

Also from this source

Capital Health Earns Third Consecutive Honor for Excellence in...

Capital Health Earns Third Consecutive Honor for Excellence in...


Saba Hasan, MD, MACP, BECOMES MEMBER OF BOARD OF REGENTS OF...

Saba Hasan, MD, MACP, BECOMES MEMBER OF BOARD OF REGENTS OF...

Explore

More news releases in similar topics

  • Health Care & Hospitals
  • Infection Control

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2022 Cision US Inc.